NRL-006 - NEUROTECHNOLOGY - Active
Interface Clinical Trials
Expanding brain-computer interface trials to new patients.
Part of Neuralink→OVERVIEW
Expanding brain-computer interface trials to new patients.
FUNDING PROGRESS
47%$28,000,000 raised of $60,000,000 goal
MISSION DETAILS
- Venture
- Neuralink
- Sector
- Neurotechnology
- Status
- Active
INVEST IN INTERFACE CLINICAL TRIALS
Neuralink · NRL-006
$40.0k – $60k
·10% DAILY ROI
$40.0k$60k
SELECTED - $40.0k